Joi Ninomoto is an experienced professional in the field of oncology clinical development and business development strategies. With a background in pharmacy and genetics, Joi has held various impactful roles in companies such as Summit Therapeutics, Pharmacyclics, Geron, and SuperGen, Inc. Currently serving as the Executive Scientific Director in Clinical Development, Joi's extensive experience and education make them a valuable asset in the pharmaceutical industry.
October, 2021 - present